Borivoj Vojtesek

15PUBLICATIONS
52CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyEvolution of developmental systemsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 23, 2026
MDM2 suppresses c-Myc synthesis by binding to the 5' mRNA translation regulatory sequence.

|Jul 02, 2025
Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties.

Martin Krkoška, Zuzana Tylichová, Pavlína Zatloukalová

|Apr 14, 2025
Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer.

Ahmet Kaynak, Subrahmanya D Vallabhapurapu, Eric P Smith

|Feb 13, 2025
TLR2-Bound Cancer-Secreted Hsp70 Induces MerTK-Mediated Immunosuppression and Tumorigenesis in Solid Tumors.

Ahmet Kaynak, Subrahmanya D Vallabhapurapu, Harold W Davis

|Oct 15, 2024
Re-appraising the evidence for the source, regulation and function of p53-family isoforms.

Ignacio López, Irene Larghero Valdivia, Borivoj Vojtesek

|Sep 05, 2024
Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis.

Lucia Martinkova, Pavlina Zatloukalova, Martina Kucerikova

Pageof 3